Stress Autism Mate (SAM) App for Stress Management in Adults With Borderline Personality Disorder Traits

March 6, 2026 updated by: Sevda Demirel, GGZ Centraal

The Effects of a Stress Management App on Enhancing Insight and Coping With Daily Stress in Adults With Borderline Personality Disorder Traits

The goal of this intervention study is to learn whether a stress management app (Stress Autism Mate, SAM) can help reduce stress and support coping in adults with borderline personality disorder traits receiving outpatient mental health care. The SAM app is a self-monitoring app designed in co-creation with and for individuals with autism, that supports users in recognizing, understanding, and managing daily stress. The app measures stress levels multiple times per day by asking what you were doing, how you were feeling and your stress signals. It offers real-time feedback and a visual overview of stress levels at both the daily and weekly level, and connecting to your activities. This allows users to recognize their own stress triggers and patterns. In addition, the app provides practical stress-reducing tips. The study focuses on changes in daily stress levels and self-reported perceived stress, coping self-efficacy, and resilience during and after use of the app.

The main questions this study aims to answer are:

  1. Does using the SAM app change daily stress levels measured within the app during four weeks of use?
  2. Does app use reduce perceived stress and improve coping self-efficacy and resilience after the intervention?

Participants will:

  • Use the SAM app on their smartphone for four weeks
  • Complete short in-app stress questionnaires multiple times per day
  • Complete online questionnaires about stress, coping, and resilience at several time points
  • Continue their regular outpatient treatment during the study

Study Overview

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amersfoort, Netherlands, 3811MG
        • GGZ Centraal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Presence of at least one borderline personality disorder (BPD) trait, as assessed according to DSM-5 criteria and the diagnostic guidelines of the Dutch Association of Psychiatry (NVVP)
  • Age 18 years or older

Exclusion Criteria:

  • inability to understand Dutch
  • inability to use a smartphone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stress Autism Mate App Intervention
Participants in this single study arm use the Stress Autism Mate mobile application during a four-week intervention period. The app prompts participants to complete brief stress questionnaires multiple times per day and provides visual feedback on stress patterns and personalized coping suggestions. The intervention is used alongside treatment as usual in outpatient mental health care. Participants serve as their own control through within-subject comparisons over time.
This intervention consists of a smartphone-based stress monitoring and coping application designed to support daily self-management of stress. The application uses ecological momentary assessment to prompt users multiple times per day to report stress-related experiences in their own environment. Based on these inputs, the app provides visual feedback on individual stress patterns over time and offers personalized coping suggestions. The intervention is low risk and self-guided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Daily Stress Scores as Measured by In-App Assessments During the Intervention Period
Time Frame: From baseline (day 1-7) to the end of the intervention period (day 8-30).
Daily stress was assessed using brief self-report stress questions embedded in the mobile application. Participants were prompted multiple times per day to rate their current level of stress. Stress scores reflect momentary perceived stress experiences and were aggregated over time for each participant. Change in daily stress was evaluated by comparing stress scores during the intervention period to the baseline phase.
From baseline (day 1-7) to the end of the intervention period (day 8-30).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Perceived Stress as Measured by the Perceived Stress Scale (PSS)
Time Frame: From baseline to pre-intervention (week 4), to post-intervention (week 8) and 4-week follow-up (week 12).
Perceived stress was assessed using the 10-item Perceived Stress Scale (PSS), a self-report questionnaire measuring the extent to which situations in life are experienced as stressful. Change in perceived stress was evaluated by comparing scores at post-intervention and follow-up to baseline.
From baseline to pre-intervention (week 4), to post-intervention (week 8) and 4-week follow-up (week 12).
Change From Baseline in Coping Self-Efficacy as Measured by the Coping Self-Efficacy Scale (CSES)
Time Frame: From baseline to pre-intervention (week 4), to post-intervention (week 8) and 4-week follow-up (week 12).
Coping self-efficacy was assessed using the Coping Self-Efficacy Scale (CSES), which measures confidence in the ability to cope with stressful situations. Changes were evaluated by comparing post-intervention and follow-up scores to baseline.
From baseline to pre-intervention (week 4), to post-intervention (week 8) and 4-week follow-up (week 12).
Change From Baseline in Resilience as Measured by the Resilience Scale (RS-NL)
Time Frame: From baseline to pre-intervention (week 4), to post-intervention (week 8) and 4-week follow-up (week 12).
Resilience was assessed using the Dutch version of the Resilience Scale (RS-NL), which measures personal competence and acceptance of self and life. Change in resilience was evaluated by comparing post-intervention and follow-up scores to baseline.
From baseline to pre-intervention (week 4), to post-intervention (week 8) and 4-week follow-up (week 12).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Yvette Roke, MD, PhD, GGZ Centraal

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 16, 2024

Primary Completion (Actual)

October 15, 2024

Study Completion (Actual)

November 12, 2024

Study Registration Dates

First Submitted

March 6, 2026

First Submitted That Met QC Criteria

March 6, 2026

First Posted (Actual)

March 11, 2026

Study Record Updates

Last Update Posted (Actual)

March 11, 2026

Last Update Submitted That Met QC Criteria

March 6, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

At this time, no public individual participant data sharing is planned, but data may be made available upon reasonable request from the corresponding author, in accordance with institutional and ethical guidelines.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder

Clinical Trials on Mobile Application for Stress Monitoring and Coping

Subscribe